These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17606674)

  • 1. Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
    Van Voorhis WC; Rivas KL; Bendale P; Nallan L; Hornéy C; Barrett LK; Bauer KD; Smart BP; Ankala S; Hucke O; Verlinde CL; Chakrabarti D; Strickland C; Yokoyama K; Buckner FS; Hamilton AD; Williams DK; Lombardo LJ; Floyd D; Gelb MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3659-71. PubMed ID: 17606674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.
    Bendale P; Olepu S; Suryadevara PK; Bulbule V; Rivas K; Nallan L; Smart B; Yokoyama K; Ankala S; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Buckner FS; Chakrabarti D; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2007 Sep; 50(19):4585-605. PubMed ID: 17722901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
    Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
    J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites.
    Glenn MP; Chang SY; Hornéy C; Rivas K; Yokoyama K; Pusateri EE; Fletcher S; Cummings CG; Buckner FS; Pendyala PR; Chakrabarti D; Sebti SM; Gelb M; Van Voorhis WC; Hamilton AD
    J Med Chem; 2006 Sep; 49(19):5710-27. PubMed ID: 16970397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.
    Gupta MK; Prabhakar YS
    Eur J Med Chem; 2008 Dec; 43(12):2751-67. PubMed ID: 18329140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.
    Bulbule VJ; Rivas K; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2008 Feb; 51(3):384-7. PubMed ID: 18198825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase.
    Eastman RT; White J; Hucke O; Yokoyama K; Verlinde CL; Hast MA; Beese LS; Gelb MH; Rathod PK; Van Voorhis WC
    Mol Biochem Parasitol; 2007 Mar; 152(1):66-71. PubMed ID: 17208314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities.
    Witschel MC; Rottmann M; Schwab A; Leartsakulpanich U; Chitnumsub P; Seet M; Tonazzi S; Schwertz G; Stelzer F; Mietzner T; McNamara C; Thater F; Freymond C; Jaruwat A; Pinthong C; Riangrungroj P; Oufir M; Hamburger M; Mäser P; Sanz-Alonso LM; Charman S; Wittlin S; Yuthavong Y; Chaiyen P; Diederich F
    J Med Chem; 2015 Apr; 58(7):3117-30. PubMed ID: 25785478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2D Chemometrics analyses of tetrahydroquinoline and ethylenediamine derivatives with antimalarial activity.
    de Freitas HF; Castilho MS
    Med Chem; 2012 Mar; 8(2):252-65. PubMed ID: 22385176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo efficacy and in vitro metabolism of 1-phenyl-3-aryl-2-propen-1-ones against Plasmodium falciparum.
    Gutteridge CE; Nichols DA; Curtis SM; Thota DS; Vo JV; Gerena L; Montip G; Asher CO; Diaz DS; Ditusa CA; Smith KS; Bhattacharjee AK
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5682-6. PubMed ID: 16908136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.
    Carrico D; Ohkanda J; Kendrick H; Yokoyama K; Blaskovich MA; Bucher CJ; Buckner FS; Van Voorhis WC; Chakrabarti D; Croft SL; Gelb MH; Sebti SM; Hamilton AD
    Bioorg Med Chem; 2004 Dec; 12(24):6517-26. PubMed ID: 15556768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.
    Glenn MP; Chang SY; Hucke O; Verlinde CL; Rivas K; Hornéy C; Yokoyama K; Buckner FS; Pendyala PR; Chakrabarti D; Gelb M; Van Voorhis WC; Sebti SM; Hamilton AD
    Angew Chem Int Ed Engl; 2005 Aug; 44(31):4903-6. PubMed ID: 16007716
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome.
    Wei S; Ji H; Yang B; Ma L; Bei Z; Li X; Dang H; Yang X; Liu C; Wu X; Chen J
    Malar J; 2015 Nov; 14():432. PubMed ID: 26537009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.
    Gujjar R; Marwaha A; El Mazouni F; White J; White KL; Creason S; Shackleford DM; Baldwin J; Charman WN; Buckner FS; Charman S; Rathod PK; Phillips MA
    J Med Chem; 2009 Apr; 52(7):1864-72. PubMed ID: 19296651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.
    Rodrigues T; da Cruz FP; Lafuente-Monasterio MJ; Gonçalves D; Ressurreição AS; Sitoe AR; Bronze MR; Gut J; Schneider G; Mota MM; Rosenthal PJ; Prudêncio M; Gamo FJ; Lopes F; Moreira R
    J Med Chem; 2013 Jun; 56(11):4811-5. PubMed ID: 23701465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
    Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
    J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
    Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
    PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
    Gonzàlez Cabrera D; Douelle F; Le Manach C; Han Z; Paquet T; Taylor D; Njoroge M; Lawrence N; Wiesner L; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
    J Med Chem; 2015 Sep; 58(18):7572-9. PubMed ID: 26322748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.